1-deoxynojirimycin has been researched along with Atherosclerosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, J; Li, Y; Wang, Y; Yu, S; Yu, Z | 1 |
| Chan, KC; Chang, WC; Huang, CN; Lin, MC; Wang, CJ | 1 |
| Hirata, A; Igarashi, M; Iwai, H; Tominaga, M | 1 |
| Aerts, JM; Bietrix, F; Groen, AK; Lombardo, E; Ottenhoff, R; Rensen, PC; van Roomen, CP; Verhoeven, AJ; Vos, M | 1 |
1 trial(s) available for 1-deoxynojirimycin and Atherosclerosis
| Article | Year |
|---|---|
Mulberry leaf attenuates atherosclerotic lesions in patients with coronary heart disease possibly via 1-Deoxynojirimycin: A placebo-controlled, double-blind clinical trial.
Topics: 1-Deoxynojirimycin; Atherosclerosis; Carotid Intima-Media Thickness; Coronary Disease; Humans; Morus; Plant Leaves | 2021 |
3 other study(ies) available for 1-deoxynojirimycin and Atherosclerosis
| Article | Year |
|---|---|
Mulberry 1-deoxynojirimycin pleiotropically inhibits glucose-stimulated vascular smooth muscle cell migration by activation of AMPK/RhoB and down-regulation of FAK.
Topics: 1-Deoxynojirimycin; AMP-Activated Protein Kinases; Animals; Atherosclerosis; Cell Line; Cell Movement; Down-Regulation; Enzyme Activation; Focal Adhesion Protein-Tyrosine Kinases; Glucose; Humans; Morus; Muscle, Smooth, Vascular; Plant Extracts; Rats; rhoB GTP-Binding Protein; Signal Transduction | 2013 |
Effect of miglitol, an alpha-glucosidase inhibitor, on atherogenic outcomes in balloon-injured diabetic rats.
Topics: 1-Deoxynojirimycin; Animals; Atherosclerosis; Blood Glucose; Catheterization; Diabetes Mellitus, Experimental; Dietary Fats; Hypoglycemic Agents; Male; Rats; Rats, Wistar | 2009 |
Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
Topics: 1-Deoxynojirimycin; Adamantane; Animals; Apolipoproteins E; Atherosclerosis; Bile; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Feces; Female; Glucosyltransferases; Glycosphingolipids; Hyperlipidemias; Kinetics; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mutation; Receptors, LDL | 2010 |